Functional tertiary lymphoid structure (TLS) and outcome in HER2-Positive Breast Cancer in the North Central Cancer Treatment Group (NCCTG) N9831 (Alliance) Trial
      Google Scholar   
Citation:
Cancer Res vol 82 (12_Supplement) 5627
Meeting Instance:
AACR 2022
Year:
2022
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Genentech  
Grants:
U10CA180821  
Corr. Author:
 
Authors:
                     
Networks:
LAPS-MN026, NY021, PR028   
Study
NCCTG-N9831
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: